## **Types of Drugs Based on Cancer Types**

Recommended Article **:** 【Bioinformatics】 [Table of Contents for Bioinformatics Analysis](https://jb243.github.io/pages/836)

Source: **NCI 2020**

---

**a.** [Pharmacology](https://jb243.github.io/pages/2197)

---

## **1\. Lymphoma** (30)

> ○ Ibritumomab tiuxetan (ZevalinⓇ)

> ○ Denileukin diftitox (OntakⓇ)

> ○ Brentuximab vedotin (AdcetrisⓇ)

> ○ Rituximab (RituxanⓇ)

> ○ Vorinostat (ZolinzaⓇ)

> ○ Romidepsin (IstodaxⓇ)

> ○ Bexarotene (TargretinⓇ)

> ○ Bortezomib (VelcadeⓇ)

> ○ Pralatrexate (FolotynⓇ)

> ○ Ibrutinib (ImbruvicaⓇ)

> ○ Siltuximab (SylvantⓇ)

> ○ Idelalisib (ZydeligⓇ)

> ○ Belinostat (BeleodaqⓇ)

> ○ Obinutuzumab (GazyvaⓇ)

> ○ Nivolumab (OpdivoⓇ)

> ○ Pembrolizumab (KeytrudaⓇ)

> ○ Rituximab & Hyaluronidase human (Rituxan Hycela™)

> ○ Copanlisib hydrochloride (Aliqopa™)

> ○ Axicabtagene ciloleucel (Yescarta™)

> ○ Acalabrutinib (CalquenceⓇ)

> ○ Tisagenlecleucel (KymriahⓇ)

> ○ Venetoclax (Venclexta™)

> ○ Mogamulizumab-kpkc (PoteligeoⓇ)

> ○ Duvelisib (Copiktra™)

> ○ Polatuzumab vedotin-piiq (Polivy™)

> ○ Zanubrutinib (Brukinsa™)

> ○ Tazemetostat hydrobromide (Tazverik™)

> ○ Selinexor (Xpovio™)

> ○ Tafasitamab-cxix (MonjuviⓇ)

> ○ Brexucabtagene autoleucel (Tecartus™)

<br>

<br>

## **2\. Leukemia** (27)

> ○ Tretinoin (VesanoidⓇ)

> ○ Imatinib mesylate (GleevecⓇ)

> ○ Dasatinib (SprycelⓇ)

> ○ Nilotinib (TasignaⓇ)

> ○ Bosutinib (BosulifⓇ)

> ○ Rituximab (RituxanⓇ)

> ○ Alemtuzumab (CampathⓇ)

> ○ Ofatumumab (ArzerraⓇ)

> ○ Obinutuzumab (GazyvaⓇ)

> ○ Ibrutinib (ImbruvicaⓇ)

> ○ Idelalisib (ZydeligⓇ)

> ○ Blinatumomab (BlincytoⓇ)

> ○ Venetoclax (Vendexta™)

> ○ Ponatinib hydrochloride (IclusigⓇ)

> ○ Midostaurin (RydaptⓇ)

> ○ Enasidenib mesylate (IdhifaⓇ)

> ○ Inotuzumab ozogamicin (BesponsaⓇ)

> ○ Tisagenledeucel (KymriahⓇ)

> ○ Gemtuzumab ozogamicin (Mylotarg™)

> ○ Rituximab & Hyaluronidase human (Rituxan Hycela™)

> ○ Ivosidenib (TibsovoⓇ)

> ○ Duvelisib (Copiktra™)

> ○ Moxetumomab pasudotox-tdfk (Lumoxiti™)

> ○ Glasdegib maleate (Daurismo™)

> ○ Gilteritinib (XospataⓇ)

> ○ Tagraxofusp-erzs (Elzonris™)

> ○ Acalabrutinib (CalquenceⓇ)

<br>

<br>

## **3\. Breast **(25)

> ○ Everolimus (AfinitorⓇ)

> ○ Tamoxifen (Nolvadex)

> ○ Toremifene (FarestonⓇ)

> ○ Trastuzumab (HerceptinⓇ)

> ○ Fulvestrant (FaslodexⓇ)

> ○ Anastrozole (ArimidexⓇ)

> ○ Exemestane (AromasinⓇ)

> ○ Lapatinib (TykerbⓇ)

> ○ Letrozole (FemaraⓇ)

> ○ Pertuzumab (PerjetaⓇ)

> ○ Ado-trastuzumab emtansine (KadcylaⓇ)

> ○ Palbociclib (IbranceⓇ)

> ○ Ribociclib (KisqaliⓇ)

> ○ Neratinib maleate (Nerlynx™)

> ○ Abemaciclib (Verzenio™)

> ○ Olaparib (Lynparza™)

> ○ Talazoparib tosylate (TalzennaⓇ)

> ○ Atezolizumab (TecentriqⓇ)

> ○ Alpelisib (PiqrayⓇ)

> ○ Fam-trastuzumab deruxtecan-nxki (EnhertuⓇ)

> ○ Tucatinib (Tukysa™)

> ○ Sacituzumab govitecan-hziy (Trodelvy™)

> ○ Pertuzumab

> ○ Trastuzumab

> ○ Hyaluronidase–zzxf (Phesgo™)

<br>

<br>

## **4\. Lung **(23)

> ○ Bevacizumab (AvastinⓇ)

> ○ Crizotinib (XalkoriⓇ)

> ○ Erlotinib (TarcevaⓇ)

> ○ Gefitinib (IressaⓇ)

> ○ Afatinib dimaleate (GilotrifⓇ)

> ○ Ceritinib (LDK378/Zykadia™)

> ○ Ramucirumab (CyramzaⓇ)

> ○ Nivolumab (OpdivoⓇ)

> ○ Pembrolizumab (KeytrudaⓇ)

> ○ Osimertinib (Tagrisso™)

> ○ Necitumumab (Portrazza™)

> ○ Alectinib (AlecensaⓇ)

> ○ Atezolizumab (TecentriqⓇ)

> ○ Brigatinib (Alunbrig™)

> ○ Trametinib (MekinistⓇ)

> ○ Dabrafenib (TafinlarⓇ)

> ○ Durvalumab (Imfinzi™)

> ○ Dacomitinib (VizimproⓇ)

> ○ Lorlatinib (LorbrenaⓇ)

> ○ Entrectinib (Rozlytrek™)

> ○ Capmatinib hydrochloride (Tabrecta™)

> ○ Ipilimumab (YervoyⓇ)

> ○ Selpercatinib (Retevmo™)

<br>

<br>

## **5\. Skin **(15)

> ○ Vismodegib (ErivedgeⓇ)

> ○ Sonidegib (OdomzoⓇ)

> ○ Ipilimumab (YervoyⓇ)

> ○ Vemurafenib (ZelborafⓇ)

> ○ Trametinib (MekinistⓇ)

> ○ Dabrafenib (TafinlarⓇ)

> ○ Pembrolizumab (KeytrudaⓇ)

> ○ Nivolumab (OpdivoⓇ)

> ○ Cobimetinib (Cotellic™)

> ○ Alitretinoin (PanretinⓇ)

> ○ Avelumab (BavencioⓇ)

> ○ Encorafenib (Braftovi™)

> ○ Binimetinib (MektoviⓇ)

> ○ Cemiplimab-rwlc (LibtayoⓇ)

> ○ Atezolizumab (TecentriqⓇ)

<br>

<br>

## **6\. Kidney **(13)

> ○ Bevacizumab (AvastinⓇ)

> ○ Sorafenib (NexavarⓇ)

> ○ Sunitinib (SutentⓇ)

> ○ Pazopanib (VotrientⓇ)

> ○ Temsirolimus (ToriselⓇ)

> ○ Everolimus (AfinitorⓇ)

> ○ Axitinib (InlytaⓇ)

> ○ Nivolumab (OpdivoⓇ)

> ○ Cabozantinib (Cabometyx™)

> ○ Lenvatinib mesylate (LenvimaⓇ)

> ○ Ipilimumab (YervoyⓇ)

> ○ Pembrolizumab (KeytrudaⓇ)

> ○ Avelumab (BavencioⓇ)

<br>

<br>

## **7\. Liver **(11)

> ○ Sorafenib (NexavarⓇ)

> ○ Regorafenib (StivargaⓇ)

> ○ Nivolumab (OpdivoⓇ)

> ○ Lenvatinib mesylate (LenvimaⓇ)

> ○ Pembrolizumab (KeytrudaⓇ)

> ○ Cabozantinib (Cabometyx™)

> ○ Ramucirumab (CyramzaⓇ)

> ○ Ipilimumab (YervoyⓇ)

> ○ Pemigatinib (Pemazyre™)

> ○ Atezolizumab (TecentriqⓇ)

> ○ Bevacizumab (AvastinⓇ)

<br>

<br>

## **8\. Colorectal **(10)

> ○ Cetuximab (ErbituxⓇ)

> ○ Panitumumab (VectibixⓇ)

> ○ Bevacizumab (AvastinⓇ)

> ○ Ziv-aflibercept (ZaltrapⓇ)

> ○ Regorafenib (StivargaⓇ)

> ○ Ramucirumab (CyramzaⓇ)

> ○ Nivolumab (OpdivoⓇ)

> ○ Ipilimumab (YervoyⓇ)

> ○ Encorafenib (Braftovi™)

> ○ Pembrolizumab (KeytrudaⓇ)

<br>

<br>

## **9\. Prostate **(8)

> ○ Cabazitaxel (JevtanaⓇ)

> ○ Enzalutamide (XtandiⓇ)

> ○ Abiraterone acetate (ZytigaⓇ)

> ○ Radium 223 dichloride (XofigoⓇ)

> ○ Apalutamide (Erleada™)

> ○ Darolutamide (NubeqaⓇ)

> ○ Rucaparib camsylate (Rubraca™)

> ○ Olaparib (Lynparza™)

<br>

<br>

## **10\. Bladder **(7)

> ○ Atezolizumab (TecentriqⓇ)

> ○ Nivolumab (OpdivoⓇ)

> ○ Durvalumab (Imfinzi™)

> ○ Avelumab (BavencioⓇ)

> ○ Pembrolizumab (KeytrudaⓇ)

> ○ Erdafitinib (Balversa™)

> ○ Enfortumab Vedotin-ejfv (Padcev™)

<br>

<br>

## **11\. Thyroid **(7)

> ○ Cabozantinib (CometriqⓇ)

> ○ Vandetanib (CaprelsaⓇ)

> ○ Sorafenib (NexavarⓇ)

> ○ Lenvatinib mesylate (LenvimaⓇ)

> ○ Trametinib (MekinistⓇ)

> ○ Dabrafenib (TafinlarⓇ)

> ○ Selpercatinib (Retevmo™)

<br>

<br>

## **12\. Targeted therapy ＜ 5**

> ○ gastric, cervical, ovarian, pancreatic, brain, head & neck, soft tissue
sarcomam, MM, etc.

<br>

---

_Input **:** 2021.12.19 22:43_
